Commentary on: Radiation With or Without Antiandrogen Therapy in Recurrent Prostate Cancer

Urology. 2017 Jun:104:5-6. doi: 10.1016/j.urology.2017.03.021. Epub 2017 Mar 22.

Authors

Werner J Struss¹, Peter C Black¹

Affiliation

¹ Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.

PMID: 28342929
DOI: 10.1016/j.urology.2017.03.021

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Aged
Androgen Antagonists / administration & dosage
Anilides / administration & dosage
Clinical Trials as Topic
Cohort Studies
Double-Blind Method
Drug Administration Schedule
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / radiotherapy*
Nitriles / administration & dosage
Prostate-Specific Antigen / blood
Prostatic Neoplasms / drug therapy*
Prostatic Neoplasms / radiotherapy*
Quality of Life
Radiotherapy
Research Design
Tosyl Compounds / administration & dosage
Treatment Outcome

Substances

Androgen Antagonists
Anilides
Nitriles
Tosyl Compounds
bicalutamide
Prostate-Specific Antigen